New York, March 20, 2018:

    Liquid Biopsy Market 2018

    The Global Liquid Biopsy Market is expected to exceed more than US$ 2 billion by 2022 and will grow at a CAGR of more than 23% in the given forecast period.

    The scope of the report includes a detailed study of global and regional markets for Global Liquid Biopsy Market with the reasons given for variations in the growth of the industry in certain regions.

    The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Biocept Inc. (U.S.), Myriad Genetics (U.S.), QIAGEN (Netherlands), Roche (Switzerland), Bio-Rad Laboratories Inc. (U.S.), Trovagene Inc. (U.S.), Guardant Health, Inc. (U.S.), Janssen Diagnostics, LLC (U.S.), Fraunhofer-Gesellschaft (Germany), and MDxHealth SA (U.S.). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

    You Can Browse Full Research Report:

    The Global Liquid Biopsy Market has been segmented as below:

    By Type of Cancer Analysis

    • Lung Cancer
    • Colorectal Cancer
    • Prostate Cancer
    • Breast Cancer
    • Liver Cancer
    • Other Cancers

    By Product and services Analysis

    • Instruments
    • Services and Software
    • Reagents

    By Circulation Biomarkers Analysis

    • Circulating Tumor Cells (CTCs)
    • Extracellular Vesicles (EVs)
    • Circulating Tumor DNA (ctDNA)
    • Other Biomarkers (Circulating RNA and Protein)

    By End User Analysis

    • academic & Research Centers
    • Reference Laboratories
    • Hospital and Physician Laboratories
    • Others End User

    By Regional Analysis

    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World

    This report provides:

    1) An overview of the global market for Liquid Biopsy and related technologies.

    2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.

    3) Identifications of new market opportunities and targeted promotional plans for Global Liquid Biopsy Market.

    4) Discussion of research and development, and the demand for new products and new applications.

    5) Comprehensive company profiles of major players in the industry.

    The Global Liquid Biopsy Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

    Request Sample Report:



    Table of Contents


    2 Research Methodology

    3 Executive Summary

    4 Premium Insights

    4.1 Liquid Biopsy: Market Overview
    4.2 Geographic Analysis: Liquid Biopsy Market, By Circulating Biomarker
    4.3 Liquid Biopsy Market Size, By End User, 2016 vs 2021
    4.4 Liquid Biopsy Market Size, By Product, 2016 vs 2021
    4.5 Liquid Biopsy Market Size, By Circulating Biomarker, 2016 vs 2021
    4.6 Geographical Snapshot of the Liquid Biopsy Market

    5 Market Overview

    6 Industry Insights

    7 Liquid Biopsy Market, By Cancer Type

    8 Liquid Biopsy Market, By Circulating Biomarker

    9 Liquid Biopsy Market, By Products and Services

    10 Liquid Biopsy Market, By End User

    11 Liquid Biopsy Market, By Region

    12 Competitive Landscape

    13 Company Profiles

    13.1 Introduction

    13.2 Biocept, Inc.

    13.3 Qiagen

    13.4 F. Hoffmann-La Roche AG

    13.5 Bio-Rad Laboratories Inc.

    13.6 Myriad Genetics

    13.7 Janssen Diagnostics, LLC.

    13.8 Tr0vagene Inc.

    13.9 Guardant Health Inc.

    13.10 Fraunhofer-Gesellschaft

    13.11 MDX Health SA



    Media Contact

    Company Name: Market Research Engine

    Contact Person: John Bay


    Phone: +1-855-984-1862

    Country: United States